Bayer is lobbying U.S. states to adjust their regulations in the battle to control costly litigation targeting its herbicide glyphosate but is also prepared for a possible exit from the market, the group’s CEO said on Thursday.
Facing weak earnings, rising legal costs and a lagging share price, Bayer hopes the strategy will p